Claims for Patent: 8,986,715

Summary for Patent: 8,986,715

Title:	Method of enhancing hair growth
Abstract:	Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I ##STR00001## wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, R.sub.1 and R.sub.2 are as defined in the specification. Such compositions are used in treating the skin or scalp of a human or non-human animal. Bimatoprost is preferred for this treatment.
Inventor(s):	Woodward; David F. (Lake Forest, CA), VanDenburgh; Amanda M. (Huntington Beach, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	14/300,902
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,986,715
Patent Claims:	1. A method for treating eyelashes, the method comprising topically administering a bimatoprost solution to an eyelid margin, wherein administration of the bimatoprost solution to the eyelid margin causes an increase in one or more eyelash attributes selected from the group consisting of length, thickness, and darkness. 2. The method of claim 1, wherein the administration causes an increase in eyelash length. 3. The method of claim 1, wherein the administration causes an increase in eyelash thickness. 4. The method of claim 1, wherein the administration causes an increase in eyelash darkness. 5. The method of claim 1, wherein the bimatoprost solution has a concentration of 0.03% by weight. 6. The method of claim 1, wherein the bimatoprost solution has a concentration of about 0.001% to about 5% by weight. 7. The method of claim 1, wherein the bimatoprost solution has a concentration of 0.03% by weight and administration thereof causes an increase in eyelash darkness. 8. The method of claim 7, wherein the bimatoprost solution is administered to an upper eyelid margin. 9. The method of claim 1, wherein the bimatoprost solution is administered to a lower eyelid margin. 10. The method of claim 7, wherein the bimatoprost solution is administered once daily. 11. A method of topically administering a bimatoprost solution, the method comprising applying a 0.03% by weight bimatoprost solution to an eyelid margin, wherein application of the bimatoprost solution causes increased darkness of the eyelashes on the eyelid margin where the bimatoprost solution is applied. 12. The method of claim 11, wherein administration of the bimatoprost solution further causes an increase in at least one eyelash attribute selected from the group consisting of eyelash length and eyelash thickness. 13. The method of claim 11, wherein the bimatoprost solution is applied to the eyelid margin once daily. 14. A method of treating eyelashes, the method comprising topically applying a 0.03% by weight bimatoprost solution to an upper eyelid margin, wherein once-daily application of the bimatoprost solution causes an increase in eyelash darkness on the eyelid margin where the bimatoprost solution is applied. 15. A method of treating eyelashes, the method comprising administering to an eyelid margin an effective amount of a solution containing about 0.03% by weight of bimatoprost, wherein administering the solution increases eyelash darkness on the eyelid margin where the solution is applied. 16. The method of claim 15, wherein the solution is administered to an upper eyelid margin. 17. The method of claim 15, wherein the solution is administered one time per day. 18. The method of claim 15, wherein administering the solution increases eyelash length. 19. The method of claim 15, wherein administering the solution increases eyelash thickness. 20. The method as in any one of claims 15-19, wherein the solution contains 0.03% by weight of bimatoprost.